Leaderboards/Antifungal resistance and susceptibility

Antifungal resistance and susceptibility

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Maria Siopi
National and Kapodistrian University of Athens
2
Itai Doron
Cornell University
3
Diana M. Proctor
The University of Texas MD Anderson Cancer Center
4
Darian J. Santana
St. Jude Children's Research Hospital
5
Malitha C. Dickwella Widanage
National Laboratory of the Rockies
6
Camille Bédard
Université Laval
7
Shen-Huan Liang
Brown University
8
Dhia Azzouz
Hospital for Sick Children
9
Arun Maji
University of Kentucky
10
Christopher Prestel
Centers for Disease Control and Prevention

Papers

1
Publication in Nature (2024) [106 citations, W4392504797]
Nature|2024
106 cit.
2
Publication in Nature Communications (2024) [66 citations, W4401184074]
Nature Communications|2024
66 cit.
3
Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost
Nature Microbiology|2024
43 cit.
4
FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistance
Nature Microbiology|2025
34 cit.
5
Evaluation of the Vitek 2 system for antifungal susceptibility testing of <i>Candida auris</i> using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance
Journal of Clinical Microbiology|2024
32 cit.
6
Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR
Nature Communications|2025
30 cit.
7
Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023
Eurosurveillance|2024
29 cit.
8
Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes
Nature|2025
28 cit.
9
Evaluation of the MIC test strips for antifungal susceptibility testing of <i>Candidozyma auris</i> ( <i>Candida auris</i> ) using a representative international collection of isolates
Journal of Clinical Microbiology|2025
8 cit.
10
A Candida auris-Specific Adhesin, Scf1, Governs Surface Association, Colonization, and Virulence
Deep Blue (University of Michigan)|2024
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Jeniel E. Nett
University of Wisconsin–Madison
2
Matthijs Backx
University Hospital of Wales
3
Frédéric Lamoth
Czech Academy of Sciences, Institute of Microbiology
4
Abha Pandey
Banaras Hindu University
5
Abdul Hakkim
Harvard University
6
Anna Selmecki
UCLA Medical Center
7
Analy Salles de Azevedo Melo
Universidade Federal de São Paulo
8
Weihua Pan
Naval Medical Research Command
9
Philipp Koehler
University Hospital Cologne
10
Shankar Thangamani
Purdue University West Lafayette

Papers

1
Pulmonary aspergillosis: diagnosis and treatment
European Respiratory Review|2022
131 cit.
2
Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study
Journal of Infection|2024
106 cit.
3
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective
Clinical Infectious Diseases|2022
77 cit.
4
Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance <i>In Vitro</i> and <i>In Vivo</i>
mBio|2022
76 cit.
5
Mechanisms of pathogenicity for the emerging fungus Candida auris
PLoS Pathogens|2023
65 cit.
6
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris
Antimicrobial Agents and Chemotherapy|2022
55 cit.
7
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in <i>Candida albicans</i>
Molecular Biology and Evolution|2023
51 cit.
8
Ex Vivo Human and Porcine Skin Effectively Model<i>Candida auris</i>Colonization, Differentiating Robust and Poor Fungal Colonizers
The Journal of Infectious Diseases|2022
37 cit.
9
Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy
Antimicrobial Agents and Chemotherapy|2023
31 cit.
10
Upc2-mediated mechanisms of azole resistance in <i>Candida auris</i>
Microbiology Spectrum|2024
28 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Thomas J. Walsh
Cornell University
2
Arturo Casadevall
Johns Hopkins University
3
David A. Stevens
Stanford University
4
David W. Denning
Manchester Academic Health Science Centre
5
Joseph Heitman
Duke University
6
Dimitrios P. Kontoyiannis
The University of Texas MD Anderson Cancer Center
7
John E. Bennett
National Institute of Allergy and Infectious Diseases
8
Paul E. Verweij
Radboud University Nijmegen
9
Mahmoud A. Ghannoum
Case Western Reserve University
10
Bernhard Hube
Czech Academy of Sciences, Institute of Microbiology

Papers

1
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases|2008
4.9k cit.
2
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2016
2.8k cit.
3
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Clinical Infectious Diseases|2008
2.7k cit.
4
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Clinical Infectious Diseases|2002
2.3k cit.
5
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Science|1991
2k cit.
6
High Capacity Anode Materials for Rechargeable Sodium-Ion Batteries
Journal of The Electrochemical Society|2000
1.8k cit.
7
Biofilm Formation by the Fungal Pathogen <i>Candida albicans</i> : Development, Architecture, and Drug Resistance
Journal of Bacteriology|2001
1.6k cit.
8
The Mechanisms of Lithium and Sodium Insertion in Carbon Materials
Journal of The Electrochemical Society|2001
1.5k cit.
9
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
Clinical Infectious Diseases|2010
1.4k cit.
10
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nature|2005
1.4k cit.

Reagents for Antifungal resistance and susceptibility

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

TIGIT (E5Y1W) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 6 papers
#17046$865
View Evidence →
Cell Signaling TechnologyEvidence 66

Smac/Diablo (79-1-83) Mouse Monoclonal Antibody

Cited in 5 papers
#2954$158,348
View Evidence →
Cell Signaling TechnologyEvidence 60

PI4 Kinase Antibody

Cited in 5 papers
#4902$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Phospho-Akt (Ser473) (D9E) Rabbit Monoclonal Antibody (Alexa Fluor® 532 Conjugate)

Cited in 8 papers
#26580$493
View Evidence →
Cell Signaling TechnologyEvidence 64

ROS1 (69D6) Mouse Monoclonal Antibody

Cited in 6 papers
#3266$158,348
View Evidence →
Cell Signaling TechnologyEvidence 65

Akt1 (C73H10) Rabbit Monoclonal Antibody

Cited in 6 papers
#2938$148,348
View Evidence →